Physician profile
Adnan Said
NPI 1669433454
$156,426.12
in general payments reported to CMS, 2019-2025
9 companies · $72K in 2025
The $72K reported for 2025 was more than what 90% of Hepatology providers received nationally (typical 2025 total: $981).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,884 · 2020: $1,711 · 2022: $6,169 · 2023: $44K · 2024: $30K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $136K · Consulting Fee: $4,120 · Travel and Lodging: $3,878 · Food and Beverage: $2,032 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $135,599.38 |
| Consulting Fee | $4,120.00 |
| Travel and Lodging | $3,878.21 |
| Food and Beverage | $2,031.66 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $78,614.10 | 2022-2025 | Terlivaz |
| Madrigal Pharmaceuticals | $36,574.99 | 2024-2025 | Rezdiffra, Resmetirom |
| Novo Nordisk INC | $36,171.61 | 2022-2025 | Wegovy |
| Gilead Sciences, INC. | $2,883.84 | 2019 | |
| Intercept Pharmaceuticals, INC. | $1,711.30 | 2020 | |
| Lantheus Medical Imaging, INC. | $350.00 | 2024 | |
| Cook Medical LLC | $120.28 | 2023 | Hemospray |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Said listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.